EVOLENT HEALTH INC - AEVH
ASignal's systematic analysis rates EVH as Bearish.
Reflects the latest available analysis · analyzed Sep 30, 2026
The case on EVH
Bull vs bear, surfaced by ASignal's framework agents from public market data. The precise verdict: ASignal Rank, confidence, and price targets - is in the app.
- Strong revenue growth (46.9% YoY)
- High free cash flow ($184.3M)
- Low forward P/E ratio (8.72x)
- Low price-to-sales (0.19x) and EV/Revenue (0.60x)
- RSI indicates oversold conditions (23.14)
- Negative net and operating margins
- Negative return on equity (-66.97%)
- High debt-to-equity ratio (2.53x)
- Declining price momentum and trading below key moving averages
- MACD bearish crossover with negative histogram
See the full verdict on EVH
ASignal Rank (1-4), confidence score, Buffett / Ackman / Dalio grades, price targets, and the full reasoning behind the call.
How ASignal analyzes EVH
Most investors never get a second opinion, let alone several. ASignal runs EVH past a panel of specialized investor-framework agents, each calibrated on a distinct school of investing: Warren Buffett's value discipline, Bill Ackman's activist lens, and Ray Dalio's macro view. They don't just score in isolation, they argue: a dedicated Challenger agent pushes back on every conclusion until the panel settles on a reasoned consensus, weighing fundamentals, macro conditions, market sentiment, and price action together. The kind of cross-examined read that takes a research desk hours, ASignal delivers in under two minutes, refreshed every cycle.
The signal direction and the bull and bear case above are free. The precise read, ASignal Rank, framework grades, price targets, and full reasoning, stays with subscribers.